Figure 3From: Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXForest plots of hazard ratios for disease-free and overall survival by p53, estrogen receptor (ER) expression and intrinsic subtype.Back to article page